Clinical impact of [18F]FDG PET/CT for initial staging in breast cancer patients prior to neoadjuvant chemotherapy

被引:0
|
作者
Duch Renom, J. [1 ]
Stefaneli, P. [1 ]
Calls, M. [1 ]
Camacho, V. [1 ]
Guzman, G. [1 ]
Andres, M. [1 ]
Fernandez Leon, A. [1 ]
Soldevila, C. [1 ]
Velasco, M. [1 ]
Castejon, S. [1 ]
Flotats, A. [1 ]
机构
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0125
引用
收藏
页码:S478 / S478
页数:1
相关论文
共 50 条
  • [21] Staging of breast cancer in pregnancy with ultralow dose [18F]-FDG-PET/CT
    Korsholm, Kirsten
    Aleksyniene, Ramune
    Albrecht-Beste, Elisabeth
    Vadstrup, Eva Soelberg
    Andersen, Flemming Littrup
    Fischer, Barbara Malene
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (05) : 1534 - 1535
  • [22] Staging of Breast Cancer with 18F-FDG PET and PET/CT
    Aukema, Tjeerd S.
    Rutgers, Emiel J. T.
    Vogel, Wouter V.
    Olmos, Renato A. Valdes
    CURRENT MEDICAL IMAGING REVIEWS, 2009, 5 (04) : 203 - 209
  • [23] Utility of [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in the initial staging and response assessment of locally advanced breast cancer patients receiving neoadjuvant chemotherapy
    Hulikal N.
    Gajjala S.R.
    Kalawat T.C.
    Kottu R.
    Yadagiri L.A.
    Indian Journal of Surgical Oncology, 2015, 6 (4) : 330 - 336
  • [24] Staging of breast cancer in pregnancy with ultralow dose [18F]-FDG-PET/CT
    Kirsten Korsholm
    Ramune Aleksyniene
    Elisabeth Albrecht-Beste
    Eva Soelberg Vadstrup
    Flemming Littrup Andersen
    Barbara Malene Fischer
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1534 - 1535
  • [25] Therapeutic impact of [18F]FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive and triple negative breast cancer
    Francois, C.
    Mailliez, A.
    Chretien, S.
    Ceugnart, L.
    Oudoux, A.
    Cougnenc, O.
    Olivier, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S477 - S477
  • [26] [18F]FDG PET-CT in staging, re staging and assessment of breast cancer response in men
    Ruiz, L. Cagua
    Luquin, T. Aroui
    Navas, D. Rivas
    Donis, A. Pinero
    Sanchez, R. Sanchez
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S481 - S481
  • [27] Prediction of the histopathological response to neoadjuvant chemotherapy by F-18-FDG PET/CT in patients with breast cancer
    Taki, Junichi
    Inokuchi, Masafumi
    Wakabayashi, Hiroshi
    Inaki, Anri
    Nakamura, Ayane
    Mochizuki, Takafumi
    Kinuya, Seigo
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [28] The impact of F-18 FDG PET/CT on axillary and distant metastasis assessment in the initial staging of breast cancer
    Arslan, E.
    Cermik, T. F.
    Trabulus, F. D.
    Kelten, E. C.
    Basaran, S. Tuter
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S476 - S476
  • [29] 18 F-FDG PET/CT for initial staging in breast cancer patients – Is there a relevant impact on treatment planning compared to conventional staging modalities?
    J. Krammer
    A. Schnitzer
    C. G. Kaiser
    K. A. Buesing
    E. Sperk
    J. Brade
    S. Wasgindt
    M. Suetterlin
    S. O. Schoenberg
    E. J. Sutton
    K. Wasser
    European Radiology, 2015, 25 : 2460 - 2469
  • [30] [18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy
    Alina Berriolo-Riedinger
    Claude Touzery
    Jean-Marc Riedinger
    Michel Toubeau
    Bruno Coudert
    Laurent Arnould
    Christophe Boichot
    Alexandre Cochet
    Pierre Fumoleau
    François Brunotte
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 1915 - 1924